These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 6295266

  • 21. In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
    Poon M, Cronin DC, Wormser GP, Bottone EJ.
    Arch Pathol Lab Med; 1988 Feb; 112(2):161-2. PubMed ID: 3276290
    [Abstract] [Full Text] [Related]

  • 22. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH, Liushih RN, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
    Still JM, Law EJ, Belcher KE, Spencer SA.
    Burns; 1995 May; 21(3):167-70. PubMed ID: 7794495
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA, Fu Y, Ibrahim AS, Mortara LA, Shafiq MC, Edwards JE, Criddle RS.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
    Gudewicz TM, Mader JT, Davis CP.
    Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
    [Abstract] [Full Text] [Related]

  • 32. Susceptibility of coccidioides immitis, Candida albicans, and Cryptococcus neoformans to amphotericin B, flucytosine, and clotrimazole.
    Hoeprich PD, Huston AC.
    J Infect Dis; 1975 Aug; 132(2):133-41. PubMed ID: 1099147
    [Abstract] [Full Text] [Related]

  • 33. In vitro comparison of the antifungal activities of R34,000, miconazole and amphotericin B.
    Dixon DM, Wagner GE, Shadomy S, Shadomy HJ.
    Chemotherapy; 1978 Aug; 24(6):364-7. PubMed ID: 699677
    [Abstract] [Full Text] [Related]

  • 34. Antifungal agents useful in therapy of systemic fungal infections.
    Medoff G, Brajtburg J, Kobayashi GS, Bolard J.
    Annu Rev Pharmacol Toxicol; 1983 Aug; 23():303-30. PubMed ID: 6307124
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
    Gebhart RJ, Espinel-Ingroff A, Shadomy S.
    Chemotherapy; 1984 Aug; 30(4):244-7. PubMed ID: 6086246
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
    Brenciaglia MI, Ghezzi MC, Cipriani P, Mancini C, Trancassini M.
    Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.